Topiramate Capsule, Extended Release
Product Images NDC 43598-939

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 43598-939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

This is information about Topiramate Extended-Release capsules, each containing 25mg of topiramate. The capsules should be swallowed whole and not opened, crushed, chewed, or sprinkled on food. The capsules have an orange opaque body and pink opaque cap. It is advised to store them in a closed container at a controlled room temperature and protect them from moisture and light. For more details on dosage and prescribing information, refer to the package insert.*

FDA Label Image

Container2 (Container2)

This is a description of a medication in the form of hard gelatin capsules containing 50 mg of Topiramate, USP as extended-release pellets. The capsules should be stored in a well-closed container at controlled room temperatures and protected from moisture and light to maintain stability. It is essential to keep the medication out of reach of children. The distributor for this medication is Dr. Reddy's Laboratories Inc, located in Princeton, NJ. The capsules are designed to be swallowed whole, and it is advised not to open, crush, chew, or sprinkle the contents on food. The codes mentioned indicate that the medication is made in India.*

FDA Label Image

Container3 (Container3)

This is a description of Topiramate Extended-Release Capsules, each containing 100 mg of topiramate as extended-release pellets. The instructions state to swallow the capsules whole and not to open, crush, chew, or sprinkle the contents on food. The capsules have a blue opaque body and a light green opaque cap. It is advised to store the capsules in a well-closed container at a controlled room temperature of 20°C to 25°C and protect from moisture and light. The distributor is mentioned as Dr. Reddy's Laboratories Inc. with a contact address in Princeton, NJ. The package insert should be referred to for dosage and other prescribing information.*

FDA Label Image

Container4 (Container4)

This is information about Topiramate Extended-Release Capsules, each containing 200 mg of Topiramate USP. The capsules are meant to be swallowed whole and should not be opened, crushed, chewed, or sprinkled on food. The capsules have a green opaque body and a brown opaque cap. The package insert contains dosage and prescribing information. The medication should be stored in a well-closed container at a controlled room temperature. The distributor is Dr. Reddy's Laboratories Inc. This product is made in India.*

FDA Label Image

Figure1 (Figure1)

This is a comparison of cumulative rates for time to first seizure between two groups: one group taking Topiramate 50 mg/day (N=234) and the other group taking Topiramate 400 mg/day (N=235). The graph shows the time in days on the x-axis and the cumulative rates on the y-axis, indicating the difference in seizure occurrence between the two dosage groups over time.*

FDA Label Image

Figure2 (Figure2)

Not available.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.